TISAGENLECLEUCEL Pharmacologic Class Indexing
- Class set ID
- 86ca3d54-ac3b-47dc-8a9d-2f4e6c881530
- Version
- 2
- Effective date
- 20220119
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use KYMRIAH safely and effectively. See full prescribing information for KYMRIAH. KYMRIAH ® (tisagenlecleucel) suspension for intravenous infusion Initial U.S. Approval: 2017 | Novartis Pharmaceuticals Corporation | 20251216 | 18 |